Fifth Third Bancorp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $220K | Sell |
4,192
-94
| -2% | -$4.97K | ﹤0.01% | 2550 |
|
|
2026
Q1 | $237K | Sell |
4,286
-3,807
| -47% | -$206K | ﹤0.01% | 2450 |
|
|
2025
Q4 | $397K | Sell |
8,093
-736
| -8% | -$34.3K | ﹤0.01% | 845 |
|
|
2025
Q3 | $381K | Sell |
8,829
-1,406
| -14% | -$54.9K | ﹤0.01% | 881 |
|
|
2025
Q2 | $393K | Buy |
10,235
+5,854
| +134% | +$224K | ﹤0.01% | 824 |
|
|
2025
Q1 | $170K | Sell |
4,381
-506
| -10% | -$18.5K | ﹤0.01% | 994 |
|
|
2024
Q4 | $165K | Sell |
4,887
-7,747
| -61% | -$279K | ﹤0.01% | 1014 |
|
|
2024
Q3 | $516K | Buy |
12,634
+808
| +7% | +$33.1K | ﹤0.01% | 771 |
|
|
2024
Q2 | $455K | Sell |
11,826
-2,123
| -15% | -$89.3K | ﹤0.01% | 772 |
|
|
2024
Q1 | $598K | Buy |
13,949
+4,977
| +55% | +$205K | ﹤0.01% | 711 |
|
|
2023
Q4 | $333K | Sell |
8,972
-880
| -9% | -$31.6K | ﹤0.01% | 856 |
|
|
2023
Q3 | $357K | Buy |
9,852
+4,246
| +76% | +$151K | ﹤0.01% | 825 |
|
|
2023
Q2 | $200K | Sell |
5,606
-867
| -13% | -$31.1K | ﹤0.01% | 966 |
|
|
2023
Q1 | $230K | Buy |
6,473
+78
| +1% | +$2.73K | ﹤0.01% | 963 |
|
|
2022
Q4 | $225K | Sell |
6,395
-5,846
| -48% | -$195K | ﹤0.01% | 912 |
|
|
2022
Q3 | $360K | Sell |
12,241
-1,512
| -11% | -$57.3K | ﹤0.01% | 782 |
|
|
2022
Q2 | $748K | Sell |
13,753
-3,091
| -18% | -$171K | ﹤0.01% | 589 |
|
|
2022
Q1 | $917K | Sell |
16,844
-893
| -5% | -$48.5K | ﹤0.01% | 587 |
|
|
2021
Q4 | $978K | Sell |
17,737
-6,558
| -27% | -$341K | ﹤0.01% | 582 |
|
|
2021
Q3 | $1.16M | Buy |
24,295
+86
| +0.4% | +$4.32K | 0.01% | 557 |
|
|
2021
Q2 | $1.21M | Sell |
24,209
-3,419
| -12% | -$164K | 0.01% | 554 |
|
|
2021
Q1 | $1.23M | Sell |
27,628
-2,474
| -8% | -$112K | 0.01% | 534 |
|
|
2020
Q4 | $1.39M | Sell |
30,102
-7,581
| -20% | -$348K | 0.01% | 490 |
|
|
2020
Q3 | $1.77M | Sell |
37,683
-14,098
| -27% | -$706K | 0.01% | 432 |
|
|
2020
Q2 | $2.64M | Sell |
51,781
-4,158
| -7% | -$213K | 0.02% | 376 |
|
|
2020
Q1 | $2.65M | Sell |
55,939
-3,283
| -6% | -$175K | 0.02% | 347 |
|
|
2019
Q4 | $3.48M | Buy |
59,222
+894
| +2% | +$49.7K | 0.02% | 355 |
|
|
2019
Q3 | $3.11M | Sell |
58,328
-8,536
| -13% | -$439K | 0.02% | 353 |
|
|
2019
Q2 | $3.35M | Buy |
66,864
+104
| +0.2% | +$5.22K | 0.02% | 337 |
|
|
2019
Q1 | $3.49M | Buy |
66,760
+1,597
| +2% | +$79.8K | 0.02% | 313 |
|
|
2018
Q4 | $3.11M | Sell |
65,163
-530
| -0.8% | -$26.1K | 0.02% | 312 |
|
|
2018
Q3 | $3.3M | Sell |
65,693
-6,343
| -9% | -$322K | 0.02% | 325 |
|
|
2018
Q2 | $3.63M | Sell |
72,036
-6,252
| -8% | -$315K | 0.02% | 310 |
|
|
2018
Q1 | $3.82M | Sell |
78,288
-4,590
| -6% | -$214K | 0.03% | 310 |
|
|
2017
Q4 | $3.67M | Sell |
82,878
-1,402
| -2% | -$64.8K | 0.03% | 313 |
|
|
2017
Q3 | $4.28M | Buy |
84,280
+4,808
| +6% | +$244K | 0.03% | 290 |
|
|
2017
Q2 | $4.28M | Buy |
79,472
+9,357
| +13% | +$499K | 0.03% | 288 |
|
|
2017
Q1 | $3.69M | Sell |
70,115
-7,690
| -10% | -$390K | 0.03% | 312 |
|
|
2016
Q4 | $3.75M | Sell |
77,805
-13,351
| -15% | -$660K | 0.03% | 327 |
|
|
2016
Q3 | $4.91M | Sell |
91,156
-2,779
| -3% | -$152K | 0.04% | 286 |
|
|
2016
Q2 | $5.09M | Buy |
93,935
+5,581
| +6% | +$294K | 0.04% | 272 |
|
|
2016
Q1 | $4.48M | Sell |
88,354
-1,004
| -1% | -$50K | 0.04% | 295 |
|
|
2015
Q4 | $4.51M | Sell |
89,358
-8,273
| -8% | -$422K | 0.04% | 287 |
|
|
2015
Q3 | $4.69M | Buy |
97,631
+1,829
| +2% | +$95.2K | 0.04% | 280 |
|
|
2015
Q2 | $4.99M | Buy |
95,802
+10,503
| +12% | +$591K | 0.04% | 274 |
|
|
2015
Q1 | $4.92M | Sell |
85,299
-33,554
| -28% | -$1.92M | 0.04% | 282 |
|
|
2014
Q4 | $6.35M | Sell |
118,853
-252
| -0.2% | -$14.1K | 0.05% | 257 |
|
|
2014
Q3 | $6.84M | Buy |
119,105
+1,735
| +1% | +$106K | 0.06% | 240 |
|
|
2014
Q2 | $7.85M | Buy |
117,370
+7,649
| +7% | +$518K | 0.07% | 230 |
|
|
2014
Q1 | $7.33M | Sell |
109,721
-2,522
| -2% | -$170K | 0.07% | 236 |
|
|
2013
Q4 | $7.49M | Buy |
112,243
+5,601
| +5% | +$363K | 0.07% | 222 |
|
|
2013
Q3 | $6.69M | Sell |
106,642
-692
| -0.6% | -$44.5K | 0.07% | 237 |
|
|
2013
Q2 | $6.7M | Buy |
+107,334
| New | +$6.81M | 0.07% | 226 |
|
Other funds holding GSK
JEST
Fifth Third Bancorp's GSK Position: Q2 2026 in Review
Fifth Third Bancorp reduced its GSK (GSK) stake by 2.2% in Q2 2026, selling an estimated $4.97K and leaving 4,192 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #2550.
Fifth Third Bancorp first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.85M in Q2 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Fifth Third Bancorp held 4,192 shares of GSK worth $220K as of Q2 2026.
- Fifth Third Bancorp sold 94 GSK shares in Q2 2026, an estimated $4.97K.
- GSK made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2550 holding.
- Fifth Third Bancorp first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Fifth Third Bancorp's GSK position peaked at $7.85M in Q2 2014.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.